<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="121144">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02062671</url>
  </required_header>
  <id_info>
    <org_study_id>RePKID</org_study_id>
    <secondary_id>S-20130085</secondary_id>
    <nct_id>NCT02062671</nct_id>
  </id_info>
  <brief_title>Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <authority>Denmark: The Ethics Comitee for Southern Denmark</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients with polycystic kidney disease, pain may be resistant to drug therapy and may
      reduce quality of life. This study investigate the effect of renal denervation on this pain.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain from VAS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (QoL)</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>SF-12v2</description>
  </secondary_outcome>
  <other_outcome>
    <measure>kidney function</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>creatinine clearance</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Adult Polycystic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>immediate renal denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>immediate renal denervation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>delayed renal denervation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>delayed renal denervation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>renal denervation</intervention_name>
    <arm_group_label>immediate renal denervation</arm_group_label>
    <arm_group_label>delayed renal denervation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pain limiting daily activities in spite of pain killers, ADPKD

        Exclusion Criteria:

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hans Dieperink, MD</last_name>
    <phone>+4520598851</phone>
    <email>hans.dieperink@rsyd.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie Blicher, MD</last_name>
    <phone>+ 45 65415305</phone>
    <email>marie.blicher@rsyd.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Nephrology</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans Dieperink, MD</last_name>
      <phone>004520598851</phone>
      <email>Hans.dieperink@rsyd.dk</email>
    </contact>
    <investigator>
      <last_name>Hans Dieperink, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 13, 2014</lastchanged_date>
  <firstreceived_date>February 12, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Hans Dieperink</investigator_full_name>
    <investigator_title>Head of Department, MD</investigator_title>
  </responsible_party>
  <keyword>ADPKD</keyword>
  <keyword>denervation</keyword>
  <keyword>renal denervation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Polycystic Kidney Diseases</mesh_term>
    <mesh_term>Polycystic Kidney, Autosomal Dominant</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
